Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
7
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
7
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
7
×
national blog main
national top stories
new york blog main
new york top stories
pfizer
7
×
raleigh-durham blog main
raleigh-durham top stories
roche
7
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
amgen
immunotherapy
merck
bristol-myers squibb
novartis
alzheimer's disease
biogen
cancer immunotherapy
celgene
clinical trials
What
bio
roundup
annual
conference
drug
medical
society
ash
cancer
clinical
crispr
esmo
european
latest
oncology
patients
plan
today
acquisitions
advantages
albert
alliance
alzheimer’s
american
bar
barcelona
biggest
blood
borne
bourla
breast
brings
bristol
buy
calls
cancer's
cancers
ceo
changing
color
Language
unset
unknown
Current search:
pfizer
×
national
×
roche
×
" boston top stories "
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front